Hyprevention Overview

  • Founded
  • 2010

Founded
  • Status
  • Private

  • Employees
  • 6

Employees
  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.27M

  • Investors
  • 3

Hyprevention General Information

Description

Operator of a medical company intended to develop implantable medical devices to address unmet clinical needs. The company's product Y-STRUT is an implantable medical device indicated for internal fixation of proximal femur of patients at risk of osteoporotic fracture and for impeding pathological fracture, enabling clinicians to treat osteoporotic and cancer patients, thus improving patients outcome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Xavier Arnozan Hospital
  • Avenue du Haut-Lévêque
  • 33604 Pessac
  • France
+33 05 00 00 00 00

Hyprevention Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyprevention Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 07-Apr-2022 $3.27M 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 28-Sep-2020 00.000 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 18-Nov-2017 $101K $908K 00.000 Completed Generating Revenue
1. Seed Round 15-Dec-2015 $807K $807K Completed Generating Revenue
To view Hyprevention’s complete valuation and funding history, request access »

Hyprevention Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 00.000000 000.0 000.0 00 000.0 0.000
Ordinary 28,838 $1.100633 $9.36 $9.36 1x $9.36 3.32%
Ordinary 59,700 $1.100633 $1.6 $1.6 1x $1.6 6.87%
To view Hyprevention’s complete cap table history, request access »

Hyprevention Patents

Hyprevention Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015342167-A1 Implant for stabilizing fractured or non-fractured bones Granted 04-Nov-2014 0000000000
JP-2017533759-A Implants for stabilizing fractured bones or non-fractured bones Granted 04-Nov-2014 0000000000
AU-2015342167-B2 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014 00000000000 0
EP-3017780-A1 Implant for stabilizing fractured or non-fractured bones Withdrawn 04-Nov-2014 0000000000 00
EP-3215037-B1 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014 A61B17/725
To view Hyprevention’s complete patent history, request access »

Hyprevention Executive Team (1)

Name Title Board Seat Contact Info
Cecile Vienney Founder & Chief Executive Officer
To view Hyprevention’s complete executive team members history, request access »

Hyprevention Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyprevention Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Be Angels Angel Group Minority 000 0000 000000 0
Business Angels Switzerland Angel Group Minority 000 0000 000000 0
Expanso Capital Corporate Venture Capital Minority 000 0000 000000 0
To view Hyprevention’s complete investors history, request access »